Semnur Pharmaceuticals, Inc. Investment Income, Net
Semnur Pharmaceuticals, Inc. (SMNR) reported Investment Income, Net of $3.09 million for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2023-11-09
- Semnur Pharmaceuticals, Inc. investment income, net for the quarter ending 2023-09-30 was $1.15M, a 202.61% increase year-over-year.
- Semnur Pharmaceuticals, Inc. investment income, net for the quarter ending 2022-09-30 was $380.43K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 6 month | Investment Income, Net 9 month |
|---|---|---|---|
| 2023-09-30 | $1.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.09M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $1.94M 10-Q · filed 2023-08-15 | ||
| 2022-09-30 | $380.43K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $495.26K 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $114.83K 10-Q · filed 2023-08-15 |